secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emergent BioSolutions Inc. (EBS)
CIK:        0001367644
Form:       8-K
Filed at:   2026-06-29T15:14:38+00:00
Accession:  0001367644-26-000068
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Emergent BioSolutions secures $52.7M contract modification from ASPR for ACAM2000 supply
--------------------------------------------------------------------------------

- $52.7M modification exercises Option Year 7 under existing 10-year ASPR contract.
- Deliveries of ACAM2000 vaccine, ancillaries, and diluent begin June 2026; diluent balance by December 2026.
- Contract supports U.S. government smallpox and mpox preparedness and response needs.
- Modification follows recent ACAM2000 approvals for mpox in Saudi Arabia and Singapore.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367644/000136764426000068/0001367644-26-000068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367644/000136764426000068/ebs-20260626.htm
  HTML page:      https://secwatch.observer/filing/0001367644-26-000068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer